[Clinical trial of baronorm in the treatment of hypertension].
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001581:Benzothiadiazines / Q000009:adverse effects / Q000627:therapeutic use*; D003248:Constipation / Q000139:chemically induced; D003499:Cyclic S-Oxides / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D011409:Propylene Glycols / Q000009:adverse effects / Q000627:therapeutic use; D046948:Secologanin Tryptamine Alkaloids / Q000009:adverse effects / Q000627:therapeutic use*; D013806:Theophylline / Q000009:adverse effects / Q000627:therapeutic use*; D014511:Uremia / Q000139:chemically induced
D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D003499:Cyclic S-Oxides; D004338:Drug Combinations; D011409:Propylene Glycols; D046948:Secologanin Tryptamine Alkaloids; D013806:Theophylline
Essai clinique du baronorme dans le traitement de l'H.T.